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Abstract In proteomics, nanoflow multidimensional chro-
matography is now the gold standard for the separation of
complex mixtures of peptides as generated by in-solution
digestion of whole-cell lysates. Ideally, the different
stationary phases used in multidimensional chromatography
should provide orthogonal separation characteristics. For
this reason, the combination of strong cation exchange
chromatography (SCX) and reversed-phase (RP) chroma-
tography is the most widely used combination for the
separation of peptides. Here, we review the potential of
hydrophilic interaction liquid chromatography (HILIC) as a
separation tool in the multidimensional separation of
peptides in proteomics applications. Recent work has
revealed that HILIC may provide an excellent alternative
to SCX, possessing several advantages in the area of
separation power and targeted analysis of protein post-
translational modifications.
Keywords HILIC . Proteomics . Post-translational
modification . Two-dimensional liquid chromatography
Introduction
Recent years have seen a significant increase of interest in
hydrophilic interaction liquid chromatography (HILIC).
Although HILIC was first introduced in the 1970s [1], it
took until the start of this century for a considerable number
of HILIC applications to appear, highlighting its versatile
nature [2–7]. A major cause of this increase is the growing
need for the analysis of polar compounds that do not bind
to reversed-phase (RP) materials and the constantly
increasing complexity of samples [8]. Additionally, the
exceptional growth of liquid chromatography–electrospray
ionisation–mass spectrometry (LC–ESI–MS) for analytical
analyses has led to a widening search for acceptable
chromatographic materials. In this search it has been noted
that the buffer conditions that are used for HILIC are highly
compatible with MS, and that the high organic contents of
these buffers can potentially increase sensitivity in ESI–MS
[9, 10]. Moreover, an HILIC separation is “orthogonal” to
RP separation, which makes it viable for the multidimen-
sional separation of complex samples [11–13]. Finally,
HILIC has been found to allow enrichment and the targeted
analysis of post-translational modifications (PTMs) such as
glycosylation [14], N-acetylation [12] and phosphorylation
[15] in proteomics applications.
Although HILIC applications cover a large range of
bioactive compounds, in this review we will focus on the
use of HILIC in proteomics. We will describe how HILIC
can be used for the separation of peptides in multidimen-
sional chromatography and provide insights into its
sensitivity, selectivity, separation power and “orthogonali-
ty.”We will also discuss how HILIC has recently been used
for the enrichment of post-translational modifications at
both peptide and protein levels.
HILIC
HILIC is characterized by the use of a hydrophilic
stationary phase and a hydrophobic organic mobile phase
[16], which was originally described by Linden et al. in
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1975 [1]. The order of elution is reversed relative to
reversed-phase chromatography (RP), with hydrophilic
compounds being retained longer than hydrophobic com-
pounds. Therefore, HILIC can simply be seen as a form of
normal-phase (NP) chromatography. However, the acronym
HILIC was suggested to distinguish it from NP, as NP is
typically performed with nonaqueous, non-water-miscible
solvent buffers, while HILIC is performed with water-
miscible solvents and elution is achieved by a water
gradient [2, 9, 17, 18].
In recent years, several stationary phases have emerged
that are specifically made for HILIC approaches. Popular
phases include underivatized silica stationary phases that
contain functional groups such as siloxanes, silanols with
(or without) a small quantity of metals [2, 9, 19, 20],
derivatized silica, such as the cation exchanger polysul-
foethyl A [17, 18], the weak cation exchanger Polycat A
[21], the weak anion exchanger PolyWAX [22, 23], TSKgel
amide 80 [24, 25], zwitterionic (ZIC)-HILIC [14] and
“click” saccharides [26]; see Fig. 1 for structures of typical
HILIC phases. Each of these materials display different
retention characteristics and separation selectivities and
require distinct buffer constitutions for optimal results [10].
A HILIC buffer typically contains more than 70%
acetonitrile [17]. Other eluents have been tested, for
instance methanol or isopropanol, but they resulted in poor
chromatography or no analyte retention [2]. It is believed
that the hydrophilic stationary phase enriches water from
the buffer and thus generates an aqueous layer [17]. This
allows for hydrophilic analytes to partition between the
hydrophilic layer and the hydrophobic elution buffer.
Elution is obtained through increasing the hydrophilicity
of the mobile phase by increasing the water content. The
final separation mechanism of elution, however, is most
probably a superpositioning of partitioning and electrostatic
interactions or hydrogen bonding to the stationary phase
[2]. The extent to which each mechanism dominates is
dependent on the actual type of stationary phase used and
the buffer conditions, including the level and type of
organic content, the type and concentration of salts and the
pH [10]. Charged stationary phases, such as the above-
mentioned anion or cation exchangers and deprotonated
silanol groups, are most likely to display some degree of
electrostatic interaction [2]. Buffering salts in the mobile
phase can decrease these electrostatic interactions through
disruption. The choice of salts is however limited, due to the
highly organic conditions of HILIC buffers, which makes it
difficult to dissolve some salts in them [10]. Typically,
ammonium acetate and formate are chosen because of their
compatibility with MS, but ammonium bicarbonate, triethyl-
amine phosphate (TEAP), sodium perchlorate and sodium
methylphosphonate (Na-MePO4) have also been found to be
applicable [2, 23]. Additionally, the same salt-based disrup-
tion can decrease the retention of analytes and can be useful
during elution [17]. However, in some instances an increase
in retention was seen upon increasing the salt concentration
[10]. This was rationalized by the suggestion of a mecha-
nism in which salt is enriched in the aqueous layer, which in
Fig. 1 Chemical structures
of the functional groups
in common HILIC
stationary phases
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turn increases the hydrophilicity of this liquid layer around
the stationary phase [10].
Unsurprisingly, the type of salt that is used can also
influence the retention behavior. It was observed that basic
peptides were retained longer with TEAP in the buffer,
while with Na-MePO4 these were the first peptides to elute
with the weak anion exchanger PolyWAX as stationary
phase [23]. It was reasoned that TEAP, as a counterion, will
generate a sublayer where one negative charge of the salt is
attracted to the positively charged stationary phase, while
the second negative charge is free to attract basic peptide
residues. In the case of Na-MePO4, there is only one
negative charge that interacts with either the stationary
phase or basic residues, leaving enough stationary phase
available for interaction with acidic peptides [23].
A special type of HILIC called electrostatic repulsion–
hydrophilic interaction chromatography (ERLIC) actually
specifically utilizes the electrostatic interactions in HILIC
[23]. In ERLIC, a stationary phase is chosen that has a
similar charge to the analytes to be separated. Analytes are
on the one hand repelled by the stationary phase but on the
other they are retained in the aqueous layer around the
stationary phase. These opposing interactions allow iso-
cratic resolution [23]. ERLIC can also be exploited in the
selective isolation of phosphopeptides from a tryptic digest
[23, 27].
Another factor that influences the retention character-
istics in HILIC is the pH of the buffer. Whether the buffer
pH is above or below the pKa of the analyte determines its
charge state, which in turn affects the hydrophilicity of the
analyte and likewise the interaction with the stationary
phase [10, 12]. For example, large differences were found
in the retention profiles of a highly complex tryptic digest
run over the same column at pH 3 and pH 8 [12]. At pH 3,
acidic peptide residues are protonated and so the overall
hydrophilicity of peptides containing these residues is
decreased, leading to poorer retention of these peptides,
with the effect being magnified with higher numbers of
acidic residues [12].
For a more detailed overview of different HILIC
stationary phases and their applications outside the field
of proteomics, see Hëmstrom et al. [2].
HILIC in multidimensional peptide separation
Shotgun proteomics involves the analysis of entire pro-
teomes in single experiments. Analysis of such samples
raises a number of issues, including enormous complexity,
large dynamic range and low levels of available analyzable
material. Often, SDS PAGE-based [28] or LC separation
techniques are used to reduce the sample complexity,
followed by RP LC-MS as the final readout. Major
advances have been made in the miniaturization of LC–
MS, since reducing the flow rate improves mass spectro-
metric sensitivity [29], reduces nonspecific adsorption onto
separation devices, and improves chromatographic resolv-
ing power [30], but improvements are still required. The
complexity of a sample can be further reduced prior to mass
spectrometric analysis by the addition of extra dimensions
of separation. At present, the method of choice is the
combination of strong cation exchange (SCX) with RP
[31–34]. Over time, a number of alternative configurations
have been developed, including size exclusion chromatog-
raphy (SEC)-RP [35, 36] and RP at pH 10 followed by RP
at pH 2.6 [37]. However, the low separation power of SEC
[36] and the correlative separation of RP at different pH
levels has not yielded the optimal two-dimensional (2D) LC
system yet.
Recently, HILIC was introduced as a dimension for 2D-
LC–MS and was shown to remove a few of the disadvan-
tages of existing techniques [11, 12]. Evidently, RP and
HILIC buffers are not directly compatible and so online
hyphenation of these stationary phases will be difficult.
Online hyphenation possesses certain advantages, such as
minimal loss of sample, no vial contamination, and no
sample dilution [38, 39]. However, performing an experi-
ment in an offline fashion is not necessarily inferior since
overloading of the second dimension is no longer an issue
with offline fractionation as it is for online approaches.
Moreover, in an offline mode, columns and/or buffers that
are normally not compatible with the two consecutive
separations can be used [38, 40]. Finally, a conventional
gradient for peptide separation can be used in offline
setups, and this has been shown to be generally superior to
step elution [40].
Gilar et al. separated and analyzed a mixture of
approximately 200 peptides using different stationary
phases, including SEC, HILIC, RP at pH 2.6 and pH 10
and SCX. HILIC was shown to have a separation power
superior to both SCX and SEC [11]. The orthogonality—
i.e., how different the separation mechanisms are—of the
stationary phases was determined by plotting the peptide
retention times of two dimensions against each other (see
Fig. 2). Although this study did not actually experimentally
connect the different stationary phases, since all LC–MS
runs were one dimensional, it revealed that HILIC is
slightly more orthogonal to RP than SCX [11].
A genuine two-dimensional HILIC–RP system was
presented recently [12]. A microliter flow-scale ZIC–HILIC
system was connected offline with a nanoliter flow-scale
RPLC–MS. For semi-automation, a microliter-scale fraction
collector was connected to the HILIC output to mix the
eluent with RP- and MS-compatible aqueous buffer and to
allow direct consecutive analysis of the HILIC fractions by
MS. In this study, a level of orthogonality to RP was found
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that matched the theoretical picture presented by Gilar et al.
[11]. SCX separation can be limited by the fact that
similarly charged peptides cluster in narrow elution
windows (see also Fig. 2), and it was shown that HILIC
did not exhibit this behavior [11, 12].
Analysis of data acquired using this two-dimensional
system shed further light on how HILIC can be orthogonal
to RP. Indeed, a separation mechanism was observed that is
based on both retention by hydrophilicity due to partition-
ing with the aqueous sublayer and retention by charge due
to electrostatic interaction with the stationary phase [11,
12]. These electrostatic interactions ensure that HILIC
separation is more than merely the reverse of RP, while
the presence of hydrophilic interactions made similarly
charged peptides elute over a wider window [12].
It was further noted that the orthogonality of ZIC–HILIC
with RP is dependent on the buffer pH. At pH 3, a higher
orthogonality was seen than at pH 6.8 and pH 8 [12].
The studies discussed so far were all performed with
HILIC columns packed with particles. A further improve-
ment in separation could be obtained by using monolithic
structures instead of porous particles. The higher porosity
of monolithic materials enables the use of longer columns
and/or higher flow rates, increasing the separation efficien-
cy without increasing the backpressure [41]. Recently,
attempts to develop HILIC columns that possess monolithic
characteristics have been reported [41–45]. Horie et al.
demonstrated the use of HILIC monoliths for peptide
separations [42]. The authors applied increased flow rates
and confirmed that short gradients of 3–10 min were
possible with 20-cm-long 200 μm ID columns, while the
peak capacities were comparable to a similar monolithic RP
setup. The poor peptide sequencing speed of a mass
spectrometer can be a potential drawback in the direct
coupling of such columns to MS. Currently, mass spec-
trometers can sequence 2–3 peptides per second, which is
significantly lower than the number of peptides that will be
delivered by the monolith column. However, such columns
are highly applicable as a first dimension, where time is not
a parameter.
HILIC is proving to be an attractive choice among the
range of separation methods available for the proteomics
researcher. The combinations chosen so far for 2D-LC–MS,
as reported in the literature, have been limited to HILIC–
RP, but the versatility of the chromatographic material will
also allow combinations such as SCX–HILIC and three-
dimensional approaches can be envisaged. The high organic
levels utilized in HILIC buffers compared to RP buffers
have the additional benefit that they improve electrospray
ionization, which increases the sensitivity of ESI–MS [9],
thus suggesting that it may be an interesting final
dimension [11].
HILIC for the analysis of PTMs
The analysis of protein PTMs is a very important albeit
challenging task in proteomics. PTMs are generally present at
much lower levels than their unmodified counterparts, which
makes it very easy to “miss them” in untargeted analyses, such
as those performed using shotgun proteomics techniques [46].
Protein modifications such as phosphorylation and glycosyl-
ation have proven to be difficult to investigate in a routine
fashion. This is mainly because these moieties are prone to
elimination and adsorption if care is not taken with sample
preparation and MS analysis protocols [14, 47]. Recently,
some of these MS problems have been overcome by using
alternative MS peptide fragmentation techniques, such as
electron capture dissociation (ECD) [48] and electron
transfer dissociation (ETD) [49]. Several approaches have
been developed to counter some of the problems presented
by the low abundance and highly labile nature of PTM
peptides. The use of chelation [50–52] or specific chromato-
graphic materials [47] have proven to be successful
strategies, and in the latter category HILIC has proven to
be a worthy addition.
Fig. 2 Two-dimensional plots
of normalized peptide retention
times in HILIC, SCX and RP
separation. Both HILIC and
SCX have separation mecha-
nisms that are orthogonal to RP,
but the clustering of similarly
charged peptides in SCX makes
this a less optimal first dimen-
sion. From the work of Gilar et
al. [11] and reproduced with
permission from the American
Chemical Society
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HILIC in the targeted analysis of phosphorylated peptides
Phosphorylation is probably the most studied protein post-
translational modification in proteomics; it provides an
important function in signal transduction, metabolic main-
tenance and cell division [53]. The development of
techniques to enrich for phosphopeptides has involved
major efforts in phosphoproteomics. One of the more
successful approaches targets the enrichment of phospho-
peptides by SCX at low pH [47]. At pH 3, acidic residues
such as glutamic and aspartic acid are neutral while
phospho-serine/threonine/tyrosine will still be negative.
Such a distinction allows proteolytic tryptic phosphopep-
tides to be separated from “normal” tryptic peptides due to
an earlier elution. However, other peptide subgroups with
reduced net charge, such as N-acetylated tryptic peptides,
will also exhibit a shorter retention time, and thus a second
level of enrichment is required to separate coeluting
nonphosphorylated peptides from phosphorylated peptides
[54]. Furthermore, the trypsinization of proteins is less
efficient for regions where phosphomoieties are present
[55]. Thus a large fraction of proteolytic phosphopeptides
will contain miscleavages (i.e., additional basic residues),
and will not be enriched. Therefore, other techniques for the
targeted enrichment of phosphopeptides are required and
are generally performed after SCX, such as those based on
immobilized metal affinity chromatography (IMAC) [50,
54] or the metal oxide TiO2 [51, 52, 56]. One other
limitation of SCX for phosphopeptide enrichment is that it
is based on poor retention. This means that multiply
phosphorylated peptides, another large subgroup, are
difficult to retain or are even lost. The use of strong anion
exchange (SAX) stationary phases immediately following
SCX retention can circumvent some of these problems [57].
The generally lower pI values of phosphopeptides will
allow stronger retentions on SAX than “normal” peptides.
However, the extra LC separation increases the analysis
time and the likelihood of sample loss.
Finally, a mixed-bed ion exchange method with both
cation and anion exchange was presented recently and was
shown to recover more normal tryptic peptides than SCX
and to exhibit orthogonal separation towards RP [58].
Phosphopeptides could be eluted by applying a single final
salt step. However, in this step only a subset of phospho-
peptides—the acidic ones—could be resolved.
HILIC is presented as an alternative enrichment tech-
nique, as it exploits the increase in hydrophilicity of
peptides through the attachment of a phosphogroup [15,
22, 23, 27]. McNulty et al. applied a TSKgel Amide-80
based HILIC system to the phosphopeptide analysis of a
Calyculin A-treated HeLa cell lysate digest. The authors
demonstrated that the system, under optimal conditions,
allowed phosphorylated peptides to be separated from
nonphosphorylated peptides and acidic peptides that might
interfere with subsequent IMAC enrichment. Interestingly,
the phosphopeptides eluted in the middle of the HILIC
separation and would also allow a considerable level of
fractionation. This rudimentary analysis permitted more
than 1000 unique phosphopeptides to be identified after
further IMAC enrichment and LC–MS analysis [15].
Ytterberg et al. evaluated the use of HILIC in a
preparative separation set-up using HILIC material packed
in micro tips [22]. Different combinations of SCX, RP and
two types of HILIC [polyhydroxyethyl aspartamide
(PHEA) and PolyWAX] were tested for the enrichment of
phosphopeptides from a saliva digest. As expected, most of
the phosphorylated peptides were retained strongly under
typical HILIC analysis conditions. Furthermore, the sepa-
ration power of the stepwise elution was sufficient to
separate peptides with differing numbers of phosphorylated
residues. The conditions used with PolyWAX are ERLIC
conditions and seem to be very useful for phosphopeptide
enrichment [23]. Normal tryptic peptides are simultaneous-
ly repelled by the weak anion exchange material and
attracted by hydrophilic interactions, while phosphopep-
tides are attracted by both. This mode of separation is very
responsive to salt contents and the pH of the buffer and can
thus be tweaked to enrich for highly phosphorylated
peptides containing up to six phosphorylated residues [22].
In contrast to these results obtained with TSKgel Amide-
80, PHEA and PolyWAX, the enrichment of phosphopep-
tides was not observed with ZIC–HILIC [12]. This might
be explained by the zwitterionic nature of this chromato-
graphic material: the negative charge could potentially repel
the phosphate group, resulting in phosphopeptides eluting
with nonphosphorylated peptides.
The microcolumn approach is a simple and undemand-
ing preparative method. However, HPLC-mode HILIC has
the potential for automation and fractionation, as the HILIC
buffers are directly compatible with IMAC and TiO2. It
might be a valuable alternative to SCX, with improved
fractionation and better retention of multiply phosphorylat-
ed peptides, and so it potentially could allow a more
comprehensive analysis of the phosphoproteome. While it
should be noted that the application of HILIC to phospho-
proteomics is still in its infancy, it is likely that the actual
power of HILIC in this field will become clear in the next
few years.
HILIC in the targeted analysis of N-terminally acetylated
peptides
The positive N-terminal charge of a protein can be
neutralized by different post-translational modifications,
each potentially influencing protein function, stability and
interaction with other biomolecules [59]. Amongst the
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biologically relevant N-terminal modifications are acetyla-
tion, methylation and myristoylation [60]. As mentioned
above, tryptic N-acetylated peptides can be enriched by
SCX [33, 54, 61]. The acetylation neutralizes the N-
terminal charge, lowering the net charge compared to the
unmodified counterpart. Therefore, N-acetylated tryptic
peptides will, like phosphopeptides, elute in the first few
SCX fractions.
ZIC–HILIC has been proposed as another means of
enriching N-acetylated tryptic peptides [12]. When it
contains a neutralized N-terminus, the hydrophilicity of an
N-acetylated peptide is decreased. This reduction in polarity
is even more pronounced at pH 3, where only basic peptide
residues are charged and acidic residues are protonated.
Through the use of a ZIC–HILIC separation and fraction-
ation, Boersema et al. showed that this subgroup of
trypsinized peptides that are N-terminally blocked could
be enriched due to their shorter retentions than “normal”
trypsinized peptides (see Fig. 3) [12]. Similarly, other
subgroups of N-terminally modified peptides, such as those
that contain an N-terminal pyroglutamic acid, were also
found primarily in the first ZIC–HILIC fractions [12].
Unfortunately, as trypsin cannot cleave acetylated lysine
residues, peptides containing this modification could not be
enriched. The miscleavage-containing K-acetylated tryptic
peptide will possess a net charge that is the same as
“normal” tryptic peptides [12].
Interestingly, and in contrast with SCX [33], no
significant enrichment of C-terminal peptides was observed
in this ZIC–HILIC set-up, although the hydrophilicity of
these peptides is also different from “normal” tryptic
peptides, due to the absence of a terminal arginine or
lysine residue. It was hypothesized that this might be
explained by the difference in charge distribution after
losing an N-terminal positive charge compared to lacking a
C-terminal positive charge. A C-terminal peptide would as
a result be more polar—and thus more hydrophilic—
compared to an N-terminally blocked peptide [12]. As
suggested above, the ZIC–HILIC method will enrich for
any peptide containing a neutralized N-terminus and thus
would be applicable as a first step in the enrichment of
formylated, carboxylated, hydroxylated, palmitoylated and
myrisotylated peptides.
HILIC in the targeted analysis of glycosylated peptides
Glycosylation, the attachment of a carbohydrate moiety to a
protein, is a frequent but very heterogeneous PTM. It
modulates the physicochemical and biological properties of
proteins and serves as a recognition determinant between
molecules, molecules and cells, or between cells [62].
Glycosylation of outer cell wall proteins are, for instance,
involved in host–pathogen interactions. It has been esti-
mated that more than half of all proteins in a biological
system are glycoproteins [63]. The heterogeneity of glycan
structures makes a global proteomics characterization of
glycosylation extremely difficult, as the signal intensity of
glycosylated peptides with the same amino acid backbone
is dispersed over peptides with different oligosaccharide
chains [64]. The proteomics analysis of glycopeptides is
made even more tedious by the fact that MS/MS data rarely
allow the confident identification of peptide sequences due
to the relatively large molecular weights of glycosylated
peptides [65] and the complex fragmentation that originates
from both peptide and glycan cleavages [14]. To overcome
some of these issues in proteomics analysis, the labile sugar
groups are often removed by deglycosylation prior to MS
analysis [66]. The problem of low glycopeptide abundance
can be tackled by enrichment techniques, mostly those
based on lectin-mediated affinity capture [66]. Recently,
HILIC was introduced as a promising additional enrichment
step for glycopeptides [14].
The hydrophilicity of glycopeptides makes them ideal
candidates for separation by HILIC. A first glycopeptide
application for HILIC was found in the analysis of
differentially sialylated glycopeptides from interferon-γ
[67]. Fractions of glycopeptides separated by RP were
further separated by HILIC. Their orthogonal retention on
the HILIC column was shown to correlate well with the
number of sialyl groups. Further studies by ESI–MS
revealed that the interaction of N-glycans with ZIC–HILIC
is based on a partitioning mechanism, while the separation
of differently sialylated N-glycans could be explained by an
Fig. 3 Distribution of phosphorylated and N-acetylated peptides over
ZIC–HILIC fractions. First dimension: ZIC-HILIC, 200 μm×160 mm,
3.5 μm, 200 Å. Flow rate 1.5 μL/min, 1 min.fractions. Number of
peptides: bare line, total; squares, N-acetylated; triangles, phosphor-
ylated. ZIC–HILIC provides clear enrichment of N-acetylated peptides
in the initial fractions. From the work of Boersema et al. [12],
reproduced with permission from the American Chemical Society
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electrostatic repulsion interaction mechanism [68]. Recent-
ly, more global proteomics approaches were reported that
targeted protein glycosites using HILIC to enrich glyco-
peptides [14, 66, 69–72]. Generally, in these approaches
glycoproteins were first selectively captured by lectin-
mediated affinity chromatography, followed by SDS-PAGE
and in-gel digestion. The peptides obtained were then
further enriched for glycosylation using ZIC–HILIC micro-
columns. The glycopeptides that were primarily found in
the later fractions were then enzymatically degycosylated
prior to MS analysis. Figure 4 shows the relative intensities
after solid-phase extraction (SPE) of a tryptic digest of
TIMP-1 with RP (R2) and HILIC microcolumns. The
relative abundance of glycopeptides was significantly
increased following enrichment by HILIC. SPE by RP
caused the matrix-assisted laser desorption/ionization
(MALDI) spectrum to be dominated by nonglycosylated
peptides, while, in comparison, SPE with HILIC resulted in
a spectrum crowded with glycosylated peptides [70].
Small diversions from this general protocol have been
reported and include lectin-mediated affinity capture at the
peptide level [69] and the further separation of glycopep-
tides by SCX [66]. It was shown that the unambiguous
localization of glycosylation sites is facilitated by leaving a
single GlcNac residue on the site [14] or by tagging the site
using 18O isotope labeling [66, 69].
Using the HILIC method, 62 glycosylation sites could be
identified for 37 glycoproteins in human plasma [14], while a
further study of the Cohn IV fraction of human plasma
revealed 103 N-glycosylation sites and 23 fucosylated N-
glycosylation sites [66]. 1465 N-glycosylated sites were
found on 829 proteins in C. elegans [72]. However, this
study was performed using three 50–200 mg samples for
affinity chromatography on three different lectin columns, and
each LC–MS analysis was performed in triplicate [72], unlike
the Cohn IV work, where a 1 mg fraction was used [66].
The glycosylation sites were determined in these studies,
but not the actual glycan structure. A few studies have used
HILIC for the desalting and enrichment [65, 70] or the
separation [73] of intact glycopeptides. However, these
studies all used relatively simple protein mixtures or even
single proteins, indicating that the unambiguous character-
ization of peptide glycan structures at the proteome level is
still rather challenging.
Fig. 4 MALDI-TOF spectra
after SPE of a tryptic digest of
TIMP-1 by RP (R2, upper
spectrum) and HILIC (lower
spectrum) microcolumns. HILIC
clearly enriches for glycopepti-
des. This figure was kindly
provided by Dr. P. Højrup
(similar to [70])
Fig. 5 HILIC separation of GluC-generated long N-terminal peptides
from histone H3.2. HILIC primary separation is controlled by the
number of acetylations (the three bigger peaks for the +butyrate
sample), and within these peaks a secondary separation is observed,
relating to the number of methylations (the narrower peaks). Adapted
by permission from Macmillan Publishers Ltd: Nature Methods [77]
Anal Bioanal Chem (2008) 391:151–159 157
These early experiments show that HILIC can be used as
an effective and relatively simple tool for the targeted
analysis of protein glycosylation. Future studies are likely
to follow, wherein HILIC might also have an important role to
play in not only glycosite elucidation but also in the com-
positional analysis of glycan structures, as HILIC was already
found to be convenient for the desalting and enrichment
[64] or even the separation [74] of glycans themselves.
HILIC in the targeted analysis of histone modifications
The regulation of the chromatin structure, and therefore DNA
transcription and replication, is driven by post-translational
modifications of the core histones. These modifications,
including methylation, acetylation, phosphorylation, sumoy-
lation and ubiquitination, are primarily found at the histone
N-terminal tails [75]. Different modifications can occur at
the same histone, and it is emerging that not just single site
modification but rather the interdependence of these
modifications is very important to regulation [76]. The
analysis of histone modifications on intact histone proteins
by MS is very demanding, due to the enormous heteroge-
neity of the modifications [77]. The separation of differen-
tially modified proteins prior to MS is therefore essential.
HILIC has been used in the last decade for the analysis
of acetylated and methylated histones [5, 7, 21, 78–80]. In
these studies, RP and HILIC phases are generally combined
to separate different histones. In analyses where LC–MS
analysis is used for the characterization of histone mod-
ifications, this is performed on the peptide level. However,
information on the interdependence of modifications is lost
due to the hydrolysis step, because different modifications
will end up at different peptides [5, 6, 79–81]. To preserve
this information, a HILIC separation of intact histones was
recently performed using a top-down MS approach, i.e., at
the level of intact proteins [77, 82]. Histone H4 was
purified by RP while HILIC was used for the further
separation of differentially modified forms. Subsequently,
these H4 HILIC fractions were analyzed by ESI–Q–FTMS/
MS with ECD fragmentation [82]. A similar but semi-
top-down approach was performed for the analysis of H3.2.
As H3.2 is not very soluble in the highly organic HILIC
buffers, GluC digestion was employed to generate a 50
amino acid-long N-terminal peptide that contains most of
the modification sites [77]. Figure 5 clearly shows the
separation power of HILIC in the analysis of histones. It
simultaneously separates acetylated and methylated his-
tones, greatly reducing the complexity of the sample.
Acetylation is the major determinant of separation. The
separation of proteins for which acetylation was induced by
butyrate resulted in more peaks at lower retention times.
The smaller peaks within these larger peaks represent
proteins with different levels of methylation.
In these histone analyses, HILIC delivered the extra
separation step that was needed to sufficiently reduce the
complexity of the samples and to separate the most
important histone modifications.
Concluding remarks
Recent years have witnessed an increased interest in HILIC.
More versatile and diverse stationary phases have become
available, leading to reports of an exciting and broad range
of applications. The unique separation and orthogonality of
HILIC towards RP (the most commonly used peptide
separation method) make it an ideal method for multidi-
mensional chromatography that can extend separation
power. As far as selectivity is concerned, HILIC can
compete well with RP and SCX, which are the two main
chromatographic techniques applied today. Focusing solely
on proteomics applications, HILIC has been shown to be very
versatile in analyses of protein modifications. The retention
of hydrophilic compounds can be effectively exploited in the
enrichment of phosphorylated, N-terminally blocked and
glycosylated peptides. Moreover, in combination with RP it
allows the separation of complex differentially modified
histones, an incredibly challenging area. It is therefore
expected that the number of applications of HILIC in the
proteomics field will increase significantly in the years to
come, and that the development of novel HILIC stationary
phases and/or monolithic columns will continue. Much
progress is expected.
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